Tucatinib is a small molecule inhibitor of HER2 used as an active pharmaceutical ingredient in the manufacturing of anticancer medications. It is primarily applied in the development and production of therapies for HER2-positive breast cancer.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 937263-43-9
Pacritinib
pharmaceutical raw material
D-Pemetrexed disodium
pharmaceutical raw material
Roxatidine acetate hydrochloride
pharmaceutical raw material
(3R,5S)-fluvastatin sodium
pharmaceutical raw material
6-N-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-4-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,6-diamine
SDEAXTCZPQIFQM-UHFFFAOYSA-N
CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5